Home

GNUbiotics Sciences is a nutrition company developing and supplying breakthrough nutritional ingredients to influence the microbiome and positively impact the gut for the food and nutrition industries.

VISION : Accelerate Metabolic Health by restoring gut equilibrium, naturally

Mission: Develop the next generation of Human Milk Oligosaccharide mimics beneficial in establishing a healthy microbiome via selective modulation.

Goals: Develop & commercialize natural ingredients applied to animal, human and medical nutrition.

Why GNUbiotics ingredients are unique?

  • Proven efficacy for selective growth of
    gut microbiota.
  • Most diverse HMO mimic product available.
  • 100% Natural source, no GMO.
GUT NATURALLY UNDERSTOOD

Based on underlying Gut Naturally Understood principles we harness benefit from complex structures with high diversity found in human and animal milk.

‘Influencing the gastrointestinal microbiome to restore gut equilibrium is increasingly viewed as the most sustainable solution for digestive disorders’

GNUbiotics is developing a family of MAC (Microbiota Accessible Carbohydrates) to reproduce the natural diversity and benefits of unique structures found in mothers’ milk.

MACs are complex carbohydrates that are resistant to digestion by a host’s metabolism, and are made available to selected gut bacteria as an energy source.

PRODUCT GNU100

First in-class microbiome modulating prebiotic for animal feed to be integrated into new pet food recipes to rebalance pets’ microbiota naturally.

GNU100 is a unique rich source of oligosaccharides, containing up to 30 different structures, including sialylated glycans, that can potentially shape intestinal microbiota for gut protection.

GNU100 has a glycan profile similar to what is observed in cat and dog milk. Sialylated glycans such as those present in GNU100 may inhibit pathogen adhesion to epithelial cell walls.

GNU100 is listed in the EU Feed Materials Register as oligosaccharide-peptide complex.

GNUbiotics’ PIPELINE OF MICROBIOTA ACCESSIBLE CARBOHYDRATES (MAC)

Our oligosaccharides complex ingredients are science based and IP protected.
Potential applications for our technology platform include functional food, medical food and dietary supplement.

Target/Indications Discovery Pre Clinical (PoC) Efficacy Market Availability
Animal Pipeline of Candidates
GNU100 Companion Animal gut health
EU
GNUXXX Specialty ingredients
Human Pipeline of Candidates
GBX Healthy microbiota (Infant born by C-section)
GMX Dysbiosis microbiota IBD (Inflammatory bowel disease)
TVX (Supplements) Immunodeficient diseases
MANAGEMENT TEAM

Richard T. Laube
Co-founder and Chairman

Jean-Philippe Kunz
Co-founder & CEO

Yemi Adesokan, PhD
Co-founder & CSO

Bernardo Horta e Costa
Co-founder & CFO

Felix Previdoli, PhD
Director, Product Manufacturing

Yong Miao, PhD
Analytics & Development Manager

Romain Wyss, PhD, PMP
Project Manager

Sara Vidal, PhD
Research Scientist, Microbiology

Mehdi Omri, PhD
Research Associate, Chemistry

SCIENTIFIC ADVISORY BOARD

Philippe Steenhout, MD Ped
Director, Medical Affairs

Prof. Dr. Kelly
Swanson

Prof. Dr. Justin
Sonnenburg

Prof. Dr. Dirk
Haller

OUR PARTNERS

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 808639

GET IN TOUCH

Gnubiotics Sciences SA
Biopole StartLab / Bat SE-B
Route de la Corniche 5
1066 Epalinges – Switzerland

Mail: info@www.gnubiotics.com
Tel: +41 79 906 92 27